...
首页> 外文期刊>American Journal of Physiology >Effect of thiazide on renal gene expression of apical calcium channels and calbindins.
【24h】

Effect of thiazide on renal gene expression of apical calcium channels and calbindins.

机译:噻嗪对顶钙通道和钙结合蛋白的肾脏基因表达的影响。

获取原文
获取原文并翻译 | 示例

摘要

Thiazide diuretics are specific inhibitors of the Na-Cl cotransporter in the distal convoluted tubule (DCT). In addition to producing diuresis and natriuresis, they have a hypocalciuric effect. Recently, two apical calcium channels have been identified, transient receptor potential vanilloid 5 (TRPV5) and TRPV6; both are expressed in the DCT. We studied the effects of thiazides on mouse renal calcium handling and renal gene expression of TRPV5 and TRPV6, as well as calbindin-D(28k) and calbindin-D(9k), both of which are calcium transport facilitators located in the DCT. Upregulation of renal TRPV5 was found 4 h after intraperitoneal injection of chlorothiazide (CTZ) at both 25 and 50 mg/kg, but not at 100 mg/kg. Chronic treatment with CTZ at 25 mg/kg twice daily for 3 days, with or without salt supplementation of 0.8% NaCl and 0.1% KCl in the drinking water, caused hypocalciuria, but the gene expression patterns were different. Without salt supplementation, mice developed volume contraction and there were no changes in gene expression. When volume contraction was prevented by salt supplementation, there was a significant increase in gene expression of TRPV5, calbindin-D(28k), and calbindin-D(9k). Salt supplementation alone also induced significant upregulation of TRPV5, TRPV6, and both calbindins. The upregulation of TRPV5 by CTZ and salt supplementation and salt alone was further confirmed with immunofluorescent staining studies. Our studies suggest that thiazides induce hypocalciuria through different mechanisms depending on volume status. With volume contraction, increased calcium reabsorption in the proximal tubule plays the major role. Without volume contraction, hypocalciuria is probably achieved through increased calcium reabsorption in the DCT by the activation of a transcellular calcium transport system and upregulation of apical calcium channel TRPV5, calbindin-D(28k), and calbindin-D(9k).
机译:噻嗪利尿剂是远曲小管(DCT)中Na-Cl共转运蛋白的特异性抑制剂。除了产生利尿和利尿作用外,它们还具有降钙作用。最近,已经确定了两个根尖钙通道,瞬时受体电位香草酸5(TRPV5)和TRPV6。两者都在DCT中表示。我们研究了噻嗪类药物对小鼠肾脏钙处理和TRPV5和TRPV6以及calbindin-D(28k)和calbindin-D(9k)的肾脏基因表达的影响,这两者都是位于DCT中的钙转运促进剂。腹腔注射氯噻嗪(CTZ)浓度为25和50 mg / kg时,但不是100 mg / kg时,发现肾脏TRPV5上调。每天两次以25 mg / kg的CTZ进行慢性治疗,连续3天,在饮用水中添加或不添加盐浓度为0.8%的NaCl和0.1%的KCl均可导致低钙尿症,但基因表达方式不同。如果不添加盐,小鼠的体积就会收缩,基因表达也没有变化。当通过补盐阻止体积收缩时,TRPV5,钙结合蛋白-D(28k)和钙结合蛋白-D(9k)的基因表达显着增加。单独添加盐也会诱导TRPV5,TRPV6和两种钙结合蛋白显着上调。通过免疫荧光染色研究进一步证实了CTZ和盐补充以及盐单独对TRPV5的上调。我们的研究表明,噻嗪类药物会根据体液状态通过不同的机制诱导低钙尿症。随着体积的收缩,近端小管中钙的重吸收增加起主要作用。在没有体积收缩的情况下,低钙尿症可能是通过激活跨细胞钙转运系统和上调钙通道TRPV5,钙结合蛋白-D(28k)和钙结合蛋白-D(9k)引起的DCT中钙的重吸收增加而实现的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号